MoneyWorks4Me

Astal Laboratories - Quaterly Results

24 May 2024 Evaluate
An increase of about 257.41% to Rs. 122.52 millions in the total revenue was observed for the quarter ended March 2024. The total revenue was pegged at Rs. 34.28 millions during the similar quarter previous year.Net Profit witnessed a 481.25% growth almost the double from Rs. 0.96 millions to Rs. 5.58  millions  of same quarter last year.Operating profit surged to 5.78 millions from the corresponding previous quarter of 1.16 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 122.52 34.28 257.41 236.48 34.28 589.85 236.48 34.28 589.85
Other Income 0.00 0.94 -100.00 0.13 1.79 -92.74 0.13 1.79 -92.74
PBIDT 5.78 1.16 398.28 11.17 0.40 2692.50 11.17 0.40 2692.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 5.78 1.16 398.28 11.17 0.40 2692.50 11.17 0.40 2692.50
Depreciation 0.20 0.04 400.00 0.30 0.08 275.00 0.30 0.08 275.00
PBT 5.58 1.12 398.21 10.87 0.32 3296.88 10.87 0.32 3296.88
TAX 0.00 0.16 0.00 3.02 0.16 1787.50 3.02 0.16 1787.50
Deferred Tax 0.00 0.06 0.00 0.08 0.06 33.33 0.08 0.06 33.33
PAT 5.58 0.96 481.25 7.85 0.16 4806.25 7.85 0.16 4806.25
Equity 98.46 39.00 152.46 98.46 39.90 146.77 98.46 39.90 146.77
PBIDTM(%) 4.72 3.38 39.41 4.72 1.17 304.78 4.72 1.17 304.78
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..